Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11 - 30; http://dx.doi.org/10.3322/caac.21166; PMID: 23335087
   PubMed Web of Science ®Google Scholar
• O’Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, et al. Acute myeloid leukemia. J Natl Compr Canc Netw 2012; 10:984 - 1021; PMID: 22878824
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD, Reed JC. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 1998; 91:991 - 1000; PMID: 9446661
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang H-G. Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors. Commun Integr Biol 2012; 5:557 - 65; http://dx.doi.org/10.4161/cib.21554; PMID: 23336025
   PubMedGoogle Scholar
• Glaser SP, Lee EF, Trounson E, Bouillet P, Wei A, Fairlie WD, Izon DJ, Zuber J, Rappaport AR, Herold MJ, et al. Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 2012; 26:120 - 5; http://dx.doi.org/10.1101/gad.182980.111; PMID: 22279045
   PubMed Web of Science ®Google Scholar
• Yoshimoto G, Miyamoto T, Jabbarzadeh-Tabrizi S, Iino T, Rocnik JL, Kikushige Y, Mori Y, Shima T, Iwasaki H, Takenaka K, et al. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Blood 2009; 114:5034 - 43; http://dx.doi.org/10.1182/blood-2008-12-196055; PMID: 19808698
   PubMed Web of Science ®Google Scholar
• Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435:677 - 81; http://dx.doi.org/10.1038/nature03579; PMID: 15902208
   PubMed Web of Science ®Google Scholar
• Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, Khaira D, Hann CL, McKeegan EM, Litvinovich E, Hemken PM, et al. Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J Clin Oncol 2011; 29:909 - 16; http://dx.doi.org/10.1200/JCO.2010.31.6208; PMID: 21282543
   PubMed Web of Science ®Google Scholar
• Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 2013; 19:202 - 8; http://dx.doi.org/10.1038/nm.3048; PMID: 23291630
   PubMed Web of Science ®Google Scholar
• Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi Y-X, Sneed T, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 2006; 10:375 - 88; http://dx.doi.org/10.1016/j.ccr.2006.10.006; PMID: 17097560
   PubMed Web of Science ®Google Scholar
• Hermanson DL, Das SG, Li Y, Xing C. Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia. Mol Pharmacol 2013; 84:236 - 43; http://dx.doi.org/10.1124/mol.113.086140; PMID: 23696245
   PubMed Web of Science ®Google Scholar
• Balakrishnan K, Burger JA, Wierda WG, Gandhi V. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Blood 2009; 113:149 - 53; http://dx.doi.org/10.1182/blood-2008-02-138560; PMID: 18836097
   PubMed Web of Science ®Google Scholar
• Aliabadi HM, Mahdipoor P, Uludağ H. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells. Cancer Gene Ther 2013; 20:169 - 77; http://dx.doi.org/10.1038/cgt.2013.8; PMID: 23449477
   PubMed Web of Science ®Google Scholar
• Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 2000; 14:23 - 7; PMID: 10640272
   PubMed Web of Science ®Google Scholar
• Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K, Korsmeyer SJ. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005; 307:1101 - 4; http://dx.doi.org/10.1126/science.1106114; PMID: 15718471
   PubMed Web of Science ®Google Scholar
• Wang X, Bathina M, Lynch J, Koss B, Calabrese C, Frase S, Schuetz JD, Rehg JE, Opferman JT. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev 2013; 27:1351 - 64; http://dx.doi.org/10.1101/gad.215855.113; PMID: 23788622
   PubMed Web of Science ®Google Scholar
• Thomas RL, Roberts DJ, Kubli DA, Lee Y, Quinsay MN, Owens JB, Fischer KM, Sussman MA, Miyamoto S, Gustafsson AB. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev 2013; 27:1365 - 77; http://dx.doi.org/10.1101/gad.215871.113; PMID: 23788623
   PubMed Web of Science ®Google Scholar
• Rahmani M, Davis EM, Bauer C, Dent P, Grant S. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem 2005; 280:35217 - 27; http://dx.doi.org/10.1074/jbc.M506551200; PMID: 16109713
   PubMed Web of Science ®Google Scholar
• Kasper S, Breitenbuecher F, Heidel F, Hoffarth S, Markova B, Schuler M, Fischer T. Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies. Blood Cancer J 2012; 2:e60; http://dx.doi.org/10.1038/bcj.2012.5; PMID: 22829255
   PubMed Web of Science ®Google Scholar
• Ma Y, Cress WD, Haura EB. Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1. Mol Cancer Ther 2003; 2:73 - 81; PMID: 12533675
   PubMed Web of Science ®Google Scholar
• Doi K, Li R, Sung S-S, Wu H, Liu Y, Manieri W, Krishnegowda G, Awwad A, Dewey A, Liu X, et al. Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation. J Biol Chem 2012; 287:10224 - 35; http://dx.doi.org/10.1074/jbc.M111.334532; PMID: 22311987
   PubMed Web of Science ®Google Scholar
• Pandey MK, Gowda K, Doi K, Sharma AK, Wang H-G, Amin S. Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cells. PLoS One 2013; 8:e78570; http://dx.doi.org/10.1371/journal.pone.0078570; PMID: 24223823
   PubMed Web of Science ®Google Scholar
• Hughes CC, Prieto-Davo A, Jensen PR, Fenical W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org Lett 2008; 10:629 - 31; http://dx.doi.org/10.1021/ol702952n; PMID: 18205372
   PubMed Web of Science ®Google Scholar
• Chen S, Dai Y, Harada H, Dent P, Grant S. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res 2007; 67:782 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-06-3964; PMID: 17234790
   PubMed Web of Science ®Google Scholar
• Yecies D, Carlson NE, Deng J, Letai A. Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 2010; 115:3304 - 13; http://dx.doi.org/10.1182/blood-2009-07-233304; PMID: 20197552
   PubMed Web of Science ®Google Scholar
• Garrido SM, Appelbaum FR, Willman CL, Banker DE. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol 2001; 29:448 - 57; http://dx.doi.org/10.1016/S0301-472X(01)00612-9; PMID: 11301185
   PubMed Web of Science ®Google Scholar
• Gores GJ, Kaufmann SH. Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors. Genes Dev 2012; 26:305 - 11; http://dx.doi.org/10.1101/gad.186189.111; PMID: 22345513
   PubMed Web of Science ®Google Scholar
• Eichhorn JM, Alford SE, Hughes CC, Fenical W, Chambers TC. Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines. Cell Death Dis 2013; 4:e880; http://dx.doi.org/10.1038/cddis.2013.411; PMID: 24157874
   PubMedGoogle Scholar
• Ding Q, He X, Hsu J-M, Xia W, Chen C-T, Li L-Y, Lee D-F, Liu J-C, Zhong Q, Wang X, et al. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol 2007; 27:4006 - 17; http://dx.doi.org/10.1128/MCB.00620-06; PMID: 17387146
   PubMed Web of Science ®Google Scholar
• Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471:104 - 9; http://dx.doi.org/10.1038/nature09732; PMID: 21368833
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007; 25:1315 - 21; http://dx.doi.org/10.1038/nbt1350; PMID: 17952057
   PubMed Web of Science ®Google Scholar
• Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994; 145:515 - 25; PMID: 8080035
   PubMed Web of Science ®Google Scholar
• Cheng C, Pan L, Chen Y, Song H, Qin Y, Li R. Total synthesis of (+/-)-marinopyrrole A and its library as potential antibiotic and anticancer agents. J Comb Chem 2010; 12:541 - 7; http://dx.doi.org/10.1021/cc100052j; PMID: 20429575
   PubMed Web of Science ®Google Scholar
• Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang H-G. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res 2007; 67:10744 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-07-3148; PMID: 18006817
   PubMed Web of Science ®Google Scholar
• Bliss CI. The calculation of microbial assays. Bacteriol Rev 1956; 20:243 - 58; PMID: 13403845
   PubMedGoogle Scholar